Vita 34 AG
XETRA:V3V

Watchlist Manager

Vita 34 AG

XETRA:V3V

Watchlist

Dividends

Discount Rate

Price: 4.16 EUR -0.95% Market Closed

Market Cap: 72.5m EUR

Have any thoughts about
Vita 34 AG?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

Add Price Alert

Price Target:

Last Price: 4.16 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

V3V Alert

Vita 34 AG

4.16

-0.04 (-0.95%)

52 Week Range	3.96 5.38
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Vita 34 AG

What unique competitive advantages
does Vita 34 AG hold over its rivals?

What risks and challenges
does Vita 34 AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Vita 34 AG.

What unique competitive advantages
does Vita 34 AG hold over its rivals?

What risks and challenges
does Vita 34 AG face in the near future?

Has there been any significant insider trading activity
in Vita 34 AG recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Vita 34 AG.

Provide P/S
for Vita 34 AG.

Provide P/E
for Vita 34 AG.

Provide P/OCF
for Vita 34 AG.

Provide P/FCFE
for Vita 34 AG.

Provide P/B
for Vita 34 AG.

Provide EV/S
for Vita 34 AG.

Provide EV/GP
for Vita 34 AG.

Provide EV/EBITDA
for Vita 34 AG.

Provide EV/EBIT
for Vita 34 AG.

Provide EV/OCF
for Vita 34 AG.

Provide EV/FCFF
for Vita 34 AG.

Provide EV/IC
for Vita 34 AG.

Show me price targets
for Vita 34 AG made by professional analysts.

What are the Revenue projections
for Vita 34 AG?

How accurate were the past Revenue estimates
for Vita 34 AG?

What are the Net Income projections
for Vita 34 AG?

How accurate were the past Net Income estimates
for Vita 34 AG?

What are the EPS projections
for Vita 34 AG?

How accurate were the past EPS estimates
for Vita 34 AG?

What are the EBIT projections
for Vita 34 AG?

How accurate were the past EBIT estimates
for Vita 34 AG?

Compare the revenue forecasts
for Vita 34 AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Vita 34 AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Vita 34 AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Vita 34 AG compared to its peers.

Compare the P/E ratios
of Vita 34 AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Vita 34 AG with its peers.

Analyze the financial leverage
of Vita 34 AG compared to its main competitors.

Show all profitability ratios
for Vita 34 AG.

Provide ROE
for Vita 34 AG.

Provide ROA
for Vita 34 AG.

Provide ROIC
for Vita 34 AG.

Provide ROCE
for Vita 34 AG.

Provide Gross Margin
for Vita 34 AG.

Provide Operating Margin
for Vita 34 AG.

Provide Net Margin
for Vita 34 AG.

Provide FCF Margin
for Vita 34 AG.

Show all solvency ratios
for Vita 34 AG.

Provide D/E Ratio
for Vita 34 AG.

Provide D/A Ratio
for Vita 34 AG.

Provide Interest Coverage Ratio
for Vita 34 AG.

Provide Altman Z-Score Ratio
for Vita 34 AG.

Provide Quick Ratio
for Vita 34 AG.

Provide Current Ratio
for Vita 34 AG.

Provide Cash Ratio
for Vita 34 AG.

What is the historical Revenue growth
over the last 5 years for Vita 34 AG?

What is the historical Net Income growth
over the last 5 years for Vita 34 AG?

What is the current Free Cash Flow
of Vita 34 AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Vita 34 AG.

EV/GP
Enterprise Value to Gross Profit

2.3

Current

6.4

Median

Industry

Lower than median

Lower than industry value

All Countries

Forward Multiples

			Market Cap	EV/GP
DE		Vita 34 AG XETRA:V3V	72.5m EUR	2.3
US		Cigna Corp NYSE:CI	91.8B USD	4.5
US	C	Cigna Group XMUN:CGN	87.7B EUR	4.5
US		CVS Health Corp NYSE:CVS	73B USD	2.4
DE		Fresenius Medical Care AG XMUN:FME	24.9B EUR	6.9
US		Laboratory Corporation of America Holdings NYSE:LH	20.1B USD	6.8
DE		Fresenius SE & Co KGaA XETRA:FRE	18.8B EUR	5.2
US		Quest Diagnostics Inc NYSE:DGX	18.3B USD	7.4
US		DaVita Inc NYSE:DVA	13.7B USD	5.3
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	12.4B EUR	4.4
AU		Sonic Healthcare Ltd ASX:SHL	13.4B AUD	2.2


DE		Vita 34 AG XETRA:V3V	Average EV/GP: 4.7 2.3
US		Cigna Corp NYSE:CI	4.5
US	C	Cigna Group XMUN:CGN	4.5
US		CVS Health Corp NYSE:CVS	2.4
DE		Fresenius Medical Care AG XMUN:FME	6.9
US		Laboratory Corporation of America Holdings NYSE:LH	6.8
DE		Fresenius SE & Co KGaA XETRA:FRE	5.2
US		Quest Diagnostics Inc NYSE:DGX	7.4
US		DaVita Inc NYSE:DVA	5.3
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	4.4
AU		Sonic Healthcare Ltd ASX:SHL	2.2

EV/GP Forward Multiples

Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/GP

N/A

2-Years Forward

EV/GP

N/A

3-Years Forward

EV/GP

N/A

Vita 34 AG
XETRA:V3V

EV/GP
Enterprise Value to Gross Profit

EV/GP Forward Multiples

See Also

Company

Help

Tools

Stocks

Vita 34 AG XETRA:V3V

EV/GP Enterprise Value to Gross Profit

EV/GP Forward Multiples

See Also

Company

Help

Tools

Stocks

Vita 34 AG
XETRA:V3V

EV/GP
Enterprise Value to Gross Profit